3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
6
Neoplasms
4
Multiple Myeloma
3
Carcinoma, Non-Small-Cell Lung
3
Brain Neoplasms
3
Sarcoma
2
Radiation Injuries
2
Osteosarcoma
2
Melanoma
2
Lung Neoplasms
2
Kidney Neoplasms
2
Head and Neck Neoplasms
2
Cognitive Dysfunction
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Thoracic Neoplasms
1
Testicular Neoplasms
1
Substance-Related Disorders
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Interventions
Surveys and Questionnaires
8
Psychiatric Rehabilitation
6
Fentanyl
4
Interviews as Topic
3
Therapeutics
2
Oxycodone
2
Mental Status and Dementia Tests
2
Analgesics, Opioid
2
ziprasidone
1
radium Ra 223 dichloride
1
pegfilgrastim
1
exemestane
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Urinary Catheterization
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Sevelamer
1
Ropivacaine
1
Rocuronium
1
Restraint, Physical
1
Rehabilitation
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiotherapy
1
Quality of Life
1
Plastic Surgery Procedures
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Pain
×
Patient Reported Outcome Measures
×
Clear all
NCT05684939
2023-06-13
CAPS
University Hospital, Clermont-Ferrand
Completed
2,010 enrolled